Departure. Clinical Miss. Billion: Should You Bet on Pfizer?
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
Monetizing social media is a great way to earn cash. Explore various strategies to turn your online presence into profit.
21,134 articlesPfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
For dividend kings long-term investors, a disciplined, income-forward approach can power wealth over two decades. Thi...
Two heavyweights vie for leadership in AI cooling and data-center resilience. This guide breaks down which stock—NVEN...
Occidental Petroleum surged after announcing a $5.8 billion debt reduction tied to the OxyChem sale and an uptick in ...
Five stalwart Dividend Aristocrats continue to anchor retirement portfolios with rising payouts, steady cash flow, an...
O-I Glass has climbed about 17% over the past year, even as a large fund unloaded roughly $80 million worth of stock....
A diversified quartet of high-yield ETFs aims to deliver monthly income above 6%. This piece breaks down how they wor...
Volatility persists into March 2026, prompting a new, diversified approach to cash flow. A four-ETF plan could target...
Inflation reshapes the real estate game. This guide explains why real estate isn’t safe and offers practical steps fo...
As investors digest Karyopharm's Q1 2026 earnings, this guide breaks down what to watch, how to interpret the numbers...
In a higher-rate environment, CDL continues to deliver a reliable monthly cash stream with a $2.29 per-share annual d...
AI networking is redefining data centers, and Arista Networks sits at the center of that shift. This article explains...